HomeVYT • BME
add
Vytrus Biotech SA
Previous close
€5.60
Day range
€5.70 - €5.70
Year range
€2.10 - €5.70
Market cap
43.52M EUR
Avg Volume
5.98K
P/E ratio
42.18
Dividend yield
-
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.53M | 38.70% |
Operating expense | 1.13M | 21.59% |
Net income | 255.14K | 174.26% |
Net profit margin | 16.69 | 97.75% |
Earnings per share | — | — |
EBITDA | 284.10K | 163.59% |
Effective tax rate | -15.62% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.53M | 128.81% |
Total assets | 11.13M | 19.50% |
Total liabilities | 3.84M | -4.57% |
Total equity | 7.29M | — |
Shares outstanding | 7.52M | — |
Price to book | 5.77 | — |
Return on assets | 5.30% | — |
Return on capital | 6.51% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 255.14K | 174.26% |
Cash from operations | 605.46K | 58.66% |
Cash from investing | -296.42K | -28.53% |
Cash from financing | -154.05K | 3.16% |
Net change in cash | 154.99K | 2,014.65% |
Free cash flow | 63.62K | 383.50% |
About
Founded
2009
Website
Employees
37
